CSDGX
Price
$16.26
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
FSSNX
Price
$28.08
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

CSDGX vs FSSNX

Header iconCSDGX vs FSSNX Comparison
Open Charts CSDGX vs FSSNXBanner chart's image
Copeland SMID Cap Dividend Growth A
Price$16.26
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Fidelity Small Cap Index
Price$28.08
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CSDGX vs FSSNX Comparison Chart
Loading...
VS
CSDGX vs. FSSNX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSDGX is a StrongSell and FSSNX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 27.3B vs. CSDGX (182M). FSSNX pays higher dividends than CSDGX: FSSNX (1.36) vs CSDGX (0.60). CSDGX was incepted earlier than FSSNX: CSDGX (6 years) vs FSSNX (13 years). FSSNX is a more actively managed with annual turnover of: 9.00 vs. CSDGX (0.02). FSSNX has a lower initial minimum investment than CSDGX: FSSNX (0) vs CSDGX (5000). FSSNX annual gain was more profitable for investors over the last year : 22.65 vs. CSDGX (14.18). FSSNX return over 5 years is better than : 44.62 vs. CSDGX (33.74).
CSDGXFSSNXCSDGX / FSSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years13 years-
Gain YTD6.0349.97261%
Front LoadN/AN/A-
Min. Initial Investment50000-
Min. Initial Investment IRAN/AN/A-
Net Assets182M27.3B1%
Annual Yield % from dividends0.601.3644%
Returns for 1 year14.1822.6563%
Returns for 3 years4.330.65666%
Returns for 5 years33.7444.6276%
Returns for 10 yearsN/A84.24-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLMD3.490.05
+1.45%
Relmada Therapeutics
BSAC20.240.18
+0.90%
Banco Santander-Chile
ODC67.85-0.79
-1.15%
Oil-Dri Corp
HRMY38.34-0.47
-1.21%
Harmony Biosciences Holdings
THAR2.94-0.05
-1.67%
Tharimmune Inc.